Form 4: Fulgent Genetics President and COO Reports Tax Withholding Transaction
SEC Form 4 Filing
Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On April 26, 2025, Jian Xie, the President and COO of Fulgent Genetics, Inc. (FLGT), reported a transaction involving common stock.
- 4,353 shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units.
- The price per share for the withholding was $18.88.
- Following the transaction, Mr. Xie directly owns 374,504 shares of common stock.
- Mr. Xie also indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.
- Mr. Xie disclaims beneficial ownership of these shares except for any pecuniary interest.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine tax withholding transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Management Comments
- Mr. Xie disclaims any beneficial interest in the shares held by The Hsieh Family Dynasty Trust except with respect to any pecuniary interest therein.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects insider activity related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| January 27, 2010 | Date of The Hsieh Family Dynasty Trust |
| November 7, 2022 | Date of the Agreement and Plan of Merger by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. |
| November 9, 2022 | Date awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission |
| April 26, 2025 | Date of the reported transaction (tax withholding) |
| April 29, 2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Fulgent Genetics, FLGT, Jian Xie, Insider Trading, Tax Withholding, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.